Quality Control of Chinese Medicines

Shaoping Li is a distinguished professor in Quality Control of Chinese Medicines and deputy director at the State Key Laboratory of Quality Research in Chinese Medicine and director of Macao Centre for Testing of Chinese Medicine, University of Macau. Dr. Li was selected in the Power List 2020: Around the World in 60 Scientists, as an expert in herbal glycoanalysis and the development of quality control methods for Chinese medicines, by analytical scientists. He is also a member of USP's Herbal Medicines Compendium-East Asia Expert Panel, an advisor of American Herbal Pharmacopoeia and a member of the Chinese Pharmacopoeia Commission. His research focuses on quality control and active components of Chinese medicines. He has published 6 books in USA and China, including Pharmacological Activity-based Quality Control of Chinese Herbs, and is also the author of over 300 peer-refereed journal papers and book chapters and holder of more than 20 China and US patents.

Jing Zhao, the National Young Qihuang Scholar of China, is an associate professor and Ph.D. supervisor of the State Key Laboratory of Quality Research in Chinese Medicine, University of Macau and the duty director of Joint Laboratory of Chinese Herbal Glycoengineering and Testing Technology, University of Macau & National Glycoengineering Research Center of China. Dr. Zhao obtained her Ph.D. degree in Pharmacognosy from China Pharmaceutical University; she is also the member of executive committee of the Collaborative Lab of the United States Pharmacopoeia Convention and University of Macau. As a specialist in quality control of Chinese medicines, she proposed the strategies of chemical standards industrialization, virtual chemical standards development for Chinese medicines and traditional Chinese medicinal materials futures. Dr. Zhao held more than more than 20 research grants with international, national, ministerial, and provincial levels. At present, Dr. Zhao focuses on thestandardization (technology-oriented) and economic evaluation (management-oriented) of Chinese medicines resources. She has published more than 200 papers including 160 SCI papers and 3 books and holds 10 invention patents.